Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00264251 · ClinicalTrials.gov registry record · NA
Diet, Exercise and/or Rosiglitazone for HIV-Associated Insulin Resistance
A NA study, sponsored by St. Luke's-Roosevelt Hospital Center.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT00264251: Completed NA study, sponsored by St. Luke's-Roosevelt Hospital Center.
NCT00264251 is a NA study that has completed, run by St. Luke's-Roosevelt Hospital Center. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00264251, a NA study, has completed, sponsored by St. Luke's-Roosevelt Hospital Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if, in men and women with excess abdominal fat and insulin resistance, people with HIV infection respond differently than people without HIV to interventions that typically improve body fat distribution and insulin resistance. The specific interventions are: 1. Diet + exercise program. 2. Rosiglitazone treatment. 3. A combination treatment of diet + exercise program and rosiglitazone.
Interventions
- BEHAVIORAL Weight loss through diet and exercise
- DRUG Rosiglitazone insulin sensitizing agent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2005-07 |
| Est. Completion | 2007-08 |
| Phase | NA |
What the finished NCT00264251 record still lists
NCT00264251 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Weight loss through diet and exercise is the first listed.
NCT00264251 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00264251 about?
NCT00264251 is a clinical study titled "Diet, Exercise and/or Rosiglitazone for HIV-Associated Insulin Resistance". The purpose of this study is to determine if, in men and women with excess abdominal fat and insulin resistance, people with HIV infection respond differently than people without HIV to interventions that typically improve body fat distribution and insulin resistance. The specific interventions are:...
What is the current status of trial NCT00264251?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2005-07. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00264251?
The interventions under investigation include: Weight loss through diet and exercise (BEHAVIORAL), Rosiglitazone insulin sensitizing agent (DRUG).
Who is sponsoring clinical trial NCT00264251?
This trial is sponsored by St. Luke's-Roosevelt Hospital Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00264251's enrollment target sits among peer trials
48 1381st of 2000 higher than 601 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia